Morrison Foerster, a leading global law firm, has advised Berlin-based Medios AG on a syndicated financing, which was provided by an international banking consortium led by Deutsche Bank.
The financing provided under the facilities agreement has, among other things, been made available to refinance existing debt, including the bridge loan for the acquisition of Ceban Pharmaceuticals B.V., and for general working capital requirements within the Medios Group.
Medios AG is a market leader in the specialty pharmaceutical sector, with a primary focus on the medical care of patients with rare and complex diseases. The company offers customized drugs and services and is Germany’s first publicly listed specialty pharmaceutical company, listed on the SDAX index.
Morrison Foerster’s team advising on the deal included: Finance partner Jennifer Seipelt, and associate Lisa Schnackenbeck; Capital Markets partner Dr. Dirk Besse; and Corporate associate Dr. Omid Ebrahimzadeh.